Insiders · Profile

Kalowski Lee

CFO and President at Q32 Bio · President and CFO at BICYCLE THERAPEUTICS · Chief Financial Officer at Eledon Pharmaceuticals. Filing since 2 Apr 2015. CIK 0001618273

Company
Date
Role
Action
Shares
Amount
Of holding
25 Aug 2026
CFO and President
Sold at will
3,972
$65.78K
2.8%
25 Feb 2026
CFO and President
Sold at will
3,995
$18.04K
10.0%
2 Dec 2025
CFO and President
Sold at will
9,072
$31.40K
18.5%
26 Aug 2025
CFO and President
Sold at will
4,240
$7.64K
8.0%
3 Apr 2023
President and CFO
Sold at will
376
$7.94K
1.2%
3 Jan 2023
President and CFO
Sold, plan not stated
1,815
$52.74K
5.6%
2 Sep 2021
President and CFO
Sold, plan not stated
10,000
$400.00K
100%
27 Aug 2021
President and CFO
Sold, plan not stated
7,950
$279.44K
100%
26 Aug 2021
President and CFO
Sold, plan not stated
550
$19.27K
100%
23 Aug 2021
President and CFO
Sold, plan not stated
7,500
$247.65K
100%
29 Jul 2021
President and CFO
Sold, plan not stated
12,500
$393.82K
100%
19 Jan 2021
President and CFO
Sold, plan not stated
15,000
$450.00K
100%
14 Jan 2021
President and CFO
Sold, plan not stated
10,000
$250.00K
100%
1 Dec 2020
President and CFO
Sold, plan not stated
7,500
$168.75K
100%
27 Nov 2020
President and CFO
Sold, plan not stated
530
$10.60K
100%
25 Nov 2020
President and CFO
Sold, plan not stated
9,781
$196.30K
100%
23 Nov 2020
President and CFO
Sold, plan not stated
17,189
$340.81K
100%
8 Sep 2015
Chief Financial Officer
Sold, plan not stated
4,668
$61.29K
10.2%
2 Sep 2015
Chief Financial Officer
Sold, plan not stated
2,158
$27.97K
4.5%
16 Apr 2015
Chief Financial Officer
Sold, plan not stated
4,567
$59.37K
8.7%
2 Apr 2015
Chief Financial Officer
Sold, plan not stated
2,258
$25.85K
4.1%
21 decisions on file.